Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Total Debt (2018 - 2025)

Historic Total Debt for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $1.8 billion.

  • AdaptHealth's Total Debt fell 1328.71% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year decrease of 1328.71%. This contributed to the annual value of $2.0 billion for FY2024, which is 776.59% down from last year.
  • AdaptHealth's Total Debt amounted to $1.8 billion in Q3 2025, which was down 1328.71% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, AdaptHealth's Total Debt ranged from a high of $2.2 billion in Q1 2023 and a low of $1.8 billion during Q3 2025
  • In the last 5 years, AdaptHealth's Total Debt had a median value of $2.2 billion in 2023 and averaged $2.1 billion.
  • As far as peak fluctuations go, AdaptHealth's Total Debt skyrocketed by 32013.05% in 2021, and later crashed by 1328.71% in 2025.
  • AdaptHealth's Total Debt (Quarter) stood at $2.2 billion in 2021, then dropped by 0.69% to $2.2 billion in 2022, then decreased by 1.84% to $2.1 billion in 2023, then decreased by 7.77% to $2.0 billion in 2024, then fell by 11.15% to $1.8 billion in 2025.
  • Its last three reported values are $1.8 billion in Q3 2025, $1.8 billion for Q2 2025, and $2.0 billion during Q1 2025.